Compliance Milestone
Eyenuk Inc., a global artificial intelligence (AI) medical technology company, is pleased to announce that it has successfully cleared an independent HIPAA audit. As a leader in real-world AI eye screening for autonomous disease detection, the team at Eyenuk Inc. understands and embraces the responsibility to keep patient data both private and secure, and they are thrilled to receive this certification which reflects their dedication to patient privacy.
In an age where major entities have gravely mishandled personal information entrusted to them by consumers, public concern regarding confidentiality and enforcement of privacy regulations including HIPAA (Health Insurance Portability and Accounting Act) has grown to an all-time high. As a response, industry regulators have fortified policies and emphasized enforcement to ensure that patient information remains confidential.
Following a recent audit by A-Lign, an accredited independent auditing agency, Eyenuk Inc. has been given the stamp of approval for adhering to best practices designed to protect patient confidentiality.
The importance of adhering to HIPAA regulations simply cannot be overstated. HIPAA certification establishes legitimacy for a business institution, instilling confidence in consumers and business partners alike that their most private and valuable information is being handled with the care and respect it demands.
HIPAA-compliant DR screening with EyeArt
Eyenuk’s EyeArt® AI Eye Screening System for autonomous detection of diabetic retinopathy (DR) has been extensively tested in the real-world on more than half million patients and nearly two million retinal images globally. The EyeArt system is designed to provide DR imaging, grading, and reporting in a single office visit without the need for expert human technicians or graders, making DR screening exams much more accessible to patients with diabetes. With the patient data involved in the use of this technology, the responsibility to keep it safe follows—a task for which Eyenuk has been deemed prepared.
The HIPAA certification is a stepping stone in helping Eyenuk expand the availability of their medical technology solutions and achieve their mission of screening every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease.